Stay updated with breaking news from Aezs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equities researchers at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $28.00 target price on shares of Aeterna Zentaris in a […]
Research analysts at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a report released on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $28.00 price target on shares of Aeterna Zentaris in a report […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 target price on shares of Aeterna Zentaris in a research note on […]
Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) was the recipient of a significant decrease in short interest in June. As of June 30th, there was short interest totalling 62,100 shares, a decrease of 13.8% from the June 15th total of 72,000 shares. Currently, 1.3% of the shares of the stock are sold short. […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 price objective on shares of Aeterna Zentaris in a research report […]